Stocksigma LogoStocksigma Logo

Ind-Swift Laboratories Approves Equity Allotment on Warrant Conversion

Ind-Swift Laboratories Limited's Preferential Issue Committee approved the allotment of 14,00,000 equity shares (face value ₹10 each) on 8th Oct'26 upon

Ind-Swift Laboratories Approves Equity Allotment on Warrant Conversion

Ind-Swift Laboratories Ltd · Others · 09 Oct 2026, 12:10 am

Ind-Swift Laboratories Approves Equity Allotment on Warrant Conversion Ind-Swift Laboratories Limited's Preferential Issue Committee approved the allotment of 14,00,000 equity shares (face value ₹10 each) on 8th Oct'26 upon conversion of fully convertible warrants issued at ₹196 each to promoter entity Essix Biosciences Limited. The conversion followed receipt of the balance 75% consideration of ₹147 per warrant, aggregating ₹20.58 Cr. Consequently, the company's paid-up equity share capital increased from ₹86.71 Cr (8,67,11,558 shares) to ₹86.96 Cr (8,69,61,558 shares).

Original exchange filing (PDF)

More announcements from Ind-Swift Laboratories Ltd

All Ind-Swift Laboratories Ltd announcements